Epitopix

At Epitopix, we discover, develop, manufacture and sell veterinary vaccines based upon our proprietary SRP® Technology. The innovative SRP® Technology induces host immunity against certain cell wall components of common Gram (-) and Gram (+) bacteria. These cell wall antigens are called Siderophore Receptors and Porins (SRP®). Our SRP® Technology is protected by an extensive portfolio of U.S. and international patents.